目次
TABLE OF CONTENTS
1. REPORT PROLOGUE
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Techniques
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Porter’s Five Forces Analysis
5.1.1. Bargaining Power of Suppliers
5.1.2. Bargaining Power of Buyers
5.1.3. Threat of New Entrants
5.1.4. Threat of Substitutes
5.1.5. Intensity of Rivalry
5.2. Value Chain Analysis
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Impact on Supply Chain
5.3.3. Impact on Demand
5.3.4. Opportunity and Threat Analysis
6. GLOBAL NANOMEDICINE MARKET, BY PRODUCT
6.1. Overview
6.2. Nanoparticles
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
6.2.1. Nanoparticles
6.2.2. Liposomes
6.2.3. Polymers & polymer-drug conjugates
6.2.4. Hydrogel nanoparticles
6.2.5. Dendrimers
6.2.6. Inorganic nanoparticles
6.3. Nano-shells
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
6.4. Nanotubes
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
6.5. Nanodevices
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
7. GLOBAL NANOMEDICINE MARKET, BY MODALITY
7.1. Overview
7.2. Diagnostics
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
7.3 Treatments
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
8. GLOBAL NANOMEDICINE MARKET, BY APPLICATION
8.1. Overview
8.2. Drug Delivery
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
8.3. Diagnostic Imaging
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
8.4. Vaccines
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
8.5. Regenerative Medicine
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
8.6. Active Implants
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
8.7. Biomaterials
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
8.8. Others
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
9. GLOBAL NANOMEDICINE MARKET, BY INDICATION
9.1. Overview
9.2. Cardiovascular diseases
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
9.3. Infectious Diseases
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
9.4. Orthopedic diseases
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
9.5. Neurological diseases
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
9.6. Oncological diseases
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
9.7. Anti-Inflammatory Disease
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
9.8. Others
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
10. GLOBAL NANOMEDICINE MARKET, BY REGION
10.1. Overview
10.2. North America
10.2.1. US
10.2.2. Canada
10.3. Europe
10.3.1. Germany
10.3.2. France
10.3.3. Italy
10.3.4. Spain
10.3.5. UK
10.3.6. Rest of Europe
10.4. Asia-Pacific
10.4.1. Japan
10.4.2. China
10.4.3. India
10.4.4. Australia
10.4.5. South Korea
10.4.6. Rest of Asia-Pacific
10.5. Rest of the World
10.5.1. Middle East & Africa
10.5.2. Latin America
11. COMPANY LANDSCAPE
11.1. Overview
11.2. Competitive Analysis
11.3. Market Share Analysis
11.4. Major Growth Strategy in the Global Nanomedicine Market
11.5. Competitive Benchmarking
11.6. Leading Players in Terms of Number of Developments in the Global Nanomedicine Market
11.7. Key Developments and Growth Strategies
11.7.1. New Product Launch/Service Deployment
11.7.2. Merger & Acquisitions
11.7.3. Joint Ventures
11.8. Major Players Financial
11.8.1. Sales & Operating Income, 2021
11.8.2. Major Players R&D Expenditure, 2021
12. COMPANY PROFILES
12.1. Pfizer Inc.
12.1.1. Company Overview
12.1.2. Products Offered
12.1.3. Financial Overview
12.1.4. Key Developments
12.1.5. SWOT Analysis
12.1.6. Key Strategies
12.2. Johnson & Johnson Services, Inc.,
12.2.1. Company Overview
12.2.2. Products Offered
12.2.3. Financial Overview
12.2.4. Key Developments
12.2.5. SWOT Analysis
12.2.6. Key Strategies
12.3. General Electric Company
12.3.1. Company Overview
12.3.2. Products Offered
12.3.3. Financial Overview
12.3.4. Key Developments
12.3.5. SWOT Analysis
12.3.6. Key Strategies
12.4. Invitae Corporation
12.4.1. Company Overview
12.4.2. Products Offered
12.4.3. Financial Overview
12.4.4. Key Developments
12.4.5. SWOT Analysis
12.4.6. Key Strategies
12.5. Leadient BioSciences Inc
12.5.1. Company Overview
12.5.2. Products Offered
12.5.3. Financial Overview
12.5.4. Key Developments
12.5.5. SWOT Analysis
12.5.6. Key Strategies
12.6. Merck & Co., Inc.
12.6.1. Company Overview
12.6.2. Products Offered
12.6.3. Financial Overview
12.6.4. Key Developments
12.6.5. SWOT Analysis
12.6.6. Key Strategies
12.7. DiaSorin S.p.A.
12.7.1. Company Overview
12.7.2. Products Offered
12.7.3. Financial Overview
12.7.4. Key Developments
12.7.5. SWOT Analysis
12.7.6. Key Strategies
12.8. Nanosphere Health Sciences, Inc.
12.8.1. Company Overview
12.8.2. Products Offered
12.8.3. Financial Overview
12.8.4. Key Developments
12.8.5. SWOT Analysis
12.8.6. Key Strategies
12.9. Celgene Corporation
12.9.1. Company Overview
12.9.2. Products Offered
12.9.3. Financial Overview
12.9.4. Key Developments
12.9.5. SWOT Analysis
12.9.6. Key Strategies
12.10. Teva Pharmaceutical Industries Ltd.
12.10.1. Company Overview
12.10.2. Products Offered
12.10.3. Financial Overview
12.10.4. Key Developments
12.10.5. SWOT Analysis
12.10.6. Key Strategies
13. APPENDIX
13.1. References
13.2. Related Reports
?
LIST OF TABLES
TABLE 1 GLOBAL NANOMEDICINE MARKET SYNOPSIS, 2022-2030
TABLE 2 GLOBAL NANOMEDICINE MARKET ESTIMATES & FORECAST, 2022-2030 (USD MILLION)
TABLE 3 GLOBAL NANOMEDICINE MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 4 GLOBAL NANOMEDICINE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 5 GLOBAL NANOMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 6 GLOBAL NANOMEDICINE MARKET, BY INDICATION, 2022-2030 (USD MILLION)
TABLE 7 NORTH AMERICA: NANOMEDICINE MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 8 NORTH AMERICA: NANOMEDICINE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 9 NORTH AMERICA: NANOMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 10 NORTH AMERICA: NANOMEDICINE MARKET, BY INDICATION, 2022-2030 (USD MILLION)
TABLE 11 US: NANOMEDICINE MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 12 US: NANOMEDICINE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 13 US: NANOMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 14 US: NANOMEDICINE MARKET, BY INDICATION, 2022-2030 (USD MILLION)
TABLE 15 CANADA: NANOMEDICINE MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 16 CANADA: NANOMEDICINE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 17 CANADA: NANOMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 18 CANADA: NANOMEDICINE MARKET, BY INDICATION, 2022-2030 (USD MILLION)
TABLE 19 EUROPE: NANOMEDICINE MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 20 EUROPE: NANOMEDICINE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 21 EUROPE: NANOMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 22 EUROPE: NANOMEDICINE MARKET, BY INDICATION, 2022-2030 (USD MILLION)
TABLE 23 GERMANY: NANOMEDICINE MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 24 GERMANY: NANOMEDICINE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 25 GERMANY: NANOMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 26 GERMANY: NANOMEDICINE MARKET, BY INDICATION, 2022-2030 (USD MILLION)
TABLE 27 UK: NANOMEDICINE MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 28 UK: NANOMEDICINE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 29 UK: NANOMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 30 UK: NANOMEDICINE MARKET, BY INDICATION, 2022-2030 (USD MILLION)
TABLE 31 FRANCE: NANOMEDICINE MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 32 FRANCE: NANOMEDICINE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 33 FRANCE: NANOMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 34 FRANCE: NANOMEDICINE MARKET BY INDICATION, 2022-2030 (USD MILLION)
TABLE 35 ITALY: NANOMEDICINE MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 36 ITALY: NANOMEDICINE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 37 ITALY: NANOMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 38 ITALY: NANOMEDICINE MARKET, BY INDICATION, 2022-2030 (USD MILLION)
TABLE 39 SPAIN: NANOMEDICINE MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 40 SPAIN: NANOMEDICINE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 41 SPAIN: NANOMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 42 SPAIN: NANOMEDICINE MARKET, BY INDICATION, 2022-2030 (USD MILLION)
TABLE 43 REST OF EUROPE: NANOMEDICINE MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 44 REST OF EUROPE: NANOMEDICINE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 45 REST OF EUROPE: NANOMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 46 REST OF EUROPE: NANOMEDICINE MARKET, BY INDICATION, 2022-2030 (USD MILLION)
TABLE 47 ASIA-PACIFIC: NANOMEDICINE MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 48 ASIA-PACIFIC: NANOMEDICINE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 49 ASIA-PACIFIC: NANOMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 50 ASIA-PACIFIC: NANOMEDICINE MARKET, BY INDICATION, 2022-2030 (USD MILLION)
TABLE 51 INDIA: NANOMEDICINE MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 52 INDIA: NANOMEDICINE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 53 INDIA: NANOMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 54 INDIA: NANOMEDICINE MARKET, BY INDICATION, 2022-2030 (USD MILLION)
TABLE 55 CHINA: NANOMEDICINE MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 56 CHINA: NANOMEDICINE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 57 CHINA: NANOMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 58 CHINA: NANOMEDICINE MARKET, BY INDICATION, 2022-2030 (USD MILLION)
TABLE 59 JAPAN: NANOMEDICINE MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 60 JAPAN: NANOMEDICINE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 61 JAPAN: NANOMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 62 JAPAN: NANOMEDICINE MARKET, BY INDICATION, 2022-2030 (USD MILLION)
TABLE 63 AUSTRALIA: NANOMEDICINE MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 64 AUSTRALIA: NANOMEDICINE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 65 AUSTRALIA: NANOMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 66 AUSTRALIA: NANOMEDICINE MARKET, BY INDICATION, 2022-2030 (USD MILLION)
TABLE 67 SOUTH KOREA: NANOMEDICINE MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 68 SOUTH KOREA: NANOMEDICINE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 69 SOUTH KOREA: NANOMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 70 SOUTH KOREA: NANOMEDICINE MARKET, BY INDICATION, 2022-2030 (USD MILLION)
TABLE 71 REST OF ASIA-PACIFIC: NANOMEDICINE MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 72 REST OF ASIA-PACIFIC: NANOMEDICINE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 73 REST OF ASIA-PACIFIC: NANOMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 74 REST OF ASIA-PACIFIC: NANOMEDICINE MARKET, BY INDICATION, 2022-2030 (USD MILLION)
TABLE 75 REST OF THE WORLD: NANOMEDICINE MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 76 REST OF THE WORLD: NANOMEDICINE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 77 REST OF THE WORLD: NANOMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 78 REST OF THE WORLD: GLOBAL NANOMEDICINE MARKET, BY INDICATION, 2022-2030 (USD MILLION)
TABLE 79 MIDDLE EAST: NANOMEDICINE MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 80 MIDDLE EAST: NANOMEDICINE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 81 MIDDLE EAST: NANOMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 82 MIDDLE EAST: NANOMEDICINE MARKET, BY INDICATION, 2022-2030 (USD MILLION)
TABLE 83 AFRICA: NANOMEDICINE MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 84 AFRICA: NANOMEDICINE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 85 AFRICA: NANOMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 86 AFRICA: NANOMEDICINE MARKET, BY INDICATION, 2022-2030 (USD MILLION)
TABLE 87 LATIN AMERICA: NANOMEDICINE MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 88 LATIN AMERICA: NANOMEDICINE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 89 LATIN AMERICA: NANOMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 90 LATIN AMERICA: NANOMEDICINE MARKET, BY INDICATION, 2022-2030 (USD MILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL NANOMEDICINE MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL NANOMEDICINE MARKET
FIGURE 4 GLOBAL NANOMEDICINE MARKET SHARE, BY PRODUCT, 2021 (%)
FIGURE 5 GLOBAL NANOMEDICINE MARKET SHARE, BY MODALITY, 2021 (%)
FIGURE 6 GLOBAL NANOMEDICINE MARKET SHARE, BY APPLICATION, 2021(%)
FIGURE 7 GLOBAL NANOMEDICINE MARKET SHARE, BY INDICATION, 2021 (%)
FIGURE 8 GLOBAL NANOMEDICINE MARKET SHARE, BY REGION, 2021 (%)
FIGURE 9 NORTH AMERICA: NANOMEDICINE MARKET SHARE, BY REGION, 2021 (%)
FIGURE 10 EUROPE: NANOMEDICINE MARKET SHARE, BY REGION, 2021 (%)
FIGURE 11 ASIA-PACIFIC: NANOMEDICINE MARKET SHARE, BY REGION, 2021 (%)
FIGURE 12 REST OF THE WORLD: NANOMEDICINE MARKET SHARE, BY REGION, 2021 (%)
FIGURE 13 GLOBAL NANOMEDICINE MARKET: COMPANY SHARE ANALYSIS, 2021 (%)
FIGURE 14 PFIZER INC.: KEY FINANCIALS
FIGURE 15 JOHNSON & JOHNSON SERVICES, INC., KEY FINANCIALS
FIGURE 16 GENERAL ELECTRIC COMPANY.: KEY FINANCIALS
FIGURE 17 INVITAE CORPORATION.: KEY FINANCIALS
FIGURE 18 LEADIENT BIOSCIENCES INC.: KEY FINANCIALS
FIGURE 19 MERCK & CO., INC.: KEY FINANCIALS
FIGURE 20 DIASORIN S.P.A.: KEY FINANCIALS
FIGURE 21 NANOSPHERE HEALTH SCIENCES, INC.: KEY FINANCIALS
FIGURE 22 CELGENE CORPORATION: KEY FINANCIALS
FIGURE 23 TEVA PHARMACEUTICAL INDUSTRIES LTD.: KEY FINANCIALS
